Anxiety disorders are the most common psychiatric illnesses in youth with prevalence rates averaging 5-20%. These disorders are associated with significant short- and long-term impairment in academic, familial, social, and psychological functioning. Although medication and cognitive-behavioral therapy (CBT) have been found to be effective in the short term, questions remain regarding the durability of treatment effects and the relative impact of intervention on long-term functioning. This competing continuation application (in response to PAR- 09-153) will continue the successful multi-site collaboration of the Child/Adolescent Anxiety Multi-modal Study (CAMS) group to conduct a 5-year follow-up of the sample of youth with anxiety disorders that participated in the CAMS trial. The six sites are: New York State Psychiatric Institute;Duke University Medical Center;Johns Hopkins University;Temple University;University of California at Los Angeles;and Western Psychiatric Institute and Clinic. The central questions of the proposed study, entitled the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS), are to examine the long-term psychiatric, physical, and functional outcomes of youth with anxiety disorders who were randomized to one of four treatment conditions (i.e., CBT, sertraline [SRT], pill placebo, or combined CBT + SRT). CAMS succeeded in randomizing 488 children/adolescents. The CAMELS is critical in light of the need for additional information about the effects of successful treatment on the course of anxiety symptoms and their sequelae and the NIMH priority to understand the developmental trajectories of mental illness (US DHHS, 2008). CAMELS will enroll the largest sample of carefully characterized youth with anxiety disorders and will inform the field about: 1) the preventive effects of successful treatment (psychosocial;medication) on the development of later psychopathology, 2) treatment durability, 3) potential long-term adverse effects (e.g., from chronic use of medication), and 4) predictors of relapse or long-term maintenance. Findings will also be used to refine current treatments, shedding light on how existing interventions may need to be augmented or personalized to target specific distal psychopathology and/or functional outcomes for specific children.

Public Health Relevance

This five-year study, entitled the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS), proposes to follow up the sample of children and adolescents (N=488) with anxiety disorders that participated in the successful multi-site collaboration of the Child/Adolescent Anxiety Multi-modal Study (CAMS;U01MH64089). The central question of the proposed study is to examine the long-term psychiatric, physical, and functional outcomes of youth with anxiety disorders who were randomized to one of four treatment conditions (i.e., cognitive behavioral therapy (CBT), sertraline (SRT), pill placebo, or combined CBT + SRT. Key findings will inform the field about the preventive effects of successful treatment (both psychosocial and medication) on the development of later psychopathology and treatment durability.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH063747-10
Application #
8449245
Study Section
Special Emphasis Panel (ZMH1-ERB-E (01))
Program Officer
Goldstein, Amy B
Project Start
2001-07-01
Project End
2015-03-31
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
10
Fiscal Year
2013
Total Cost
$116,768
Indirect Cost
$40,449
Name
Temple University
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Hale, Amy E; Ginsburg, Golda S; Chan, Grace et al. (2018) Mediators of Treatment Outcomes for Anxious Children and Adolescents: The Role of Somatic Symptoms. J Clin Child Adolesc Psychol 47:94-104
Swan, Anna J; Kendall, Philip C; Olino, Thomas et al. (2018) Results from the Child/Adolescent Anxiety Multimodal Longitudinal Study (CAMELS): Functional outcomes. J Consult Clin Psychol 86:738-750
Palitz, Sophie A; Caporino, Nicole E; McGuire, Joseph F et al. (2018) Defining Treatment Response and Remission in Youth Anxiety: A Signal Detection Analysis With the Multidimensional Anxiety Scale for Children. J Am Acad Child Adolesc Psychiatry 57:418-427
Hoff, Alexandra L; Kendall, Philip C; Langley, Audra et al. (2017) Developmental Differences in Functioning in Youth With Social Phobia. J Clin Child Adolesc Psychol 46:686-694
Wallace, Meredith L; McMakin, Dana L; Tan, Patricia Z et al. (2017) The role of day-to-day emotions, sleep, and social interactions in pediatric anxiety treatment. Behav Res Ther 90:87-95
Caporino, Nicole E; Read, Kendra L; Shiffrin, Nina et al. (2017) Sleep-Related Problems and the Effects of Anxiety Treatment in Children and Adolescents. J Clin Child Adolesc Psychol 46:675-685
Wolk, Courtney Benjamin; Caporino, Nicole E; McQuarrie, Susanna et al. (2016) Parental Attitudes, Beliefs, and Understanding of Anxiety (PABUA): Development and psychometric properties of a measure. J Anxiety Disord 39:71-78
Caporino, Nicole E; Herres, Joanna; Kendall, Philip C et al. (2016) Dysregulation in Youth with Anxiety Disorders: Relationship to Acute and 7- to 19- Year Follow-Up Outcomes of Cognitive-Behavioral Therapy. Child Psychiatry Hum Dev 47:539-47
Kendall, Philip C; Cummings, Colleen M; Villabø, Marianne A et al. (2016) Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study. J Consult Clin Psychol 84:1-14
Wolk, Courtney Benjamin; Carper, Matthew M; Kendall, Philip C et al. (2016) Pathways to anxiety-depression comorbidity: A longitudinal examination of childhood anxiety disorders. Depress Anxiety 33:978-986

Showing the most recent 10 out of 45 publications